Tadehagi triquetrum
Tadehagi triquetrum · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Tadehagi triquetrum is a botanical species that has garnered significant scientific interest due to its diverse pharmacological potential. Research indicates that its aqueous and ethanol extracts possess notable antidiabetic activities, making it a subject of study for metabolic health. The plant's therapeutic profile is driven by key chemical constituents, including Tadehaginoside, Neohesperidin, baicalein, and naringin. Beyond managing glucose levels, studies suggest its compounds may impact conditions such as asthma, atherosclerosis, and cellular senescence. Consequently, this plant serves as a promising natural resource for developing interventions against various chronic ailments.
- Synonyms
- Desmodium Auriculatum · Tadehagi Andamanicum · 12 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Tadehagi triquetrum is a versatile plant known by several distinct regional names across different cultures. In certain areas, it is commonly referred to as Daun Duduk or Trefle Gros. Its identity is further reflected in East Asian nomenclature, where it is recognized as タデハギ(広義). In Chinese contexts, the species is also identified by the names 思茅蒲桃 and 葫芦茶. These various common names highlight the widespread botanical recognition of this unique plant.
Sources: Catalogue of Life (COL)
Synonyms
Tadehagi triquetrum is a botanical species that has been classified under several different scientific names throughout history. It is widely recognized by the synonym Aeschynomene triquetra in various taxonomic records. Furthermore, the plant has been identified as Desmodium acrocarpum and Desmodium auriculatum in different studies. Its complex nomenclature also includes the designation Desmodium triquetrum. Finally, some researchers have specifically categorized it as the subspecies Desmodium triquetrum subsp. auriculatum.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Tadehagi triquetrum is a distinct biological entity belonging to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida, marking its place among the vascular plants. The species is further organized into the order Fabales, a group that reflects its evolutionary lineage. As a member of the family Fabaceae, it shares characteristics with other well-known legumes. Ultimately, this plant is defined by its placement within the specific genus Tadehagi.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Tadehagi |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Tadehagi triquetrum is a plant species primarily distributed throughout the Asia-Temperate regions. Its presence is notably widespread across China, encompassing South-Central and Southeast territories as well as the island of Hainan. The species also extends its reach into Eastern Asia, specifically inhabiting the Nansei-shoto islands. Furthermore, its range includes the significant landmass of Taiwan. These diverse locations highlight the plant's adaptability within various East Asian ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Tadehagi triquetrum is a self-supporting plant that typically takes on a shrub-like growth form. It maintains a compact presence in the landscape, reaching a maximum height of only 1 meter. This modest stature makes it an ideal choice for structured garden borders or low-level greenery.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Tadehagi triquetrum has emerged as a significant subject of pharmacological interest due to its potential antidiabetic properties. Recent studies have successfully isolated ten new phenylpropanoid glucosides, known as tadehaginosides A-J, from this plant species. Research specifically highlights that these compounds, particularly compound 4, significantly enhance both basal and insulin-elicited glucose uptake in C2C12 myotubes. This biological effect is driven by the upregulation of PPARγ activity and the increased expression of the glucose transporter GLUT-4. Consequently, these findings suggest that derivatives from Tadehagi triquetrum hold great promise for the development of new therapeutic agents to manage diabetes.
Compounds
Tadehagi triquetrum is a medicinal plant that possesses a diverse profile of bioactive chemical constituents. Research has identified that this species contains several phenylpropanoid glucosides, most notably tadehaginoside, which shows promise in modulating lipogenesis and glucose consumption. In addition to these glycosides, the plant's roots serve as a source of important flavonoids. Specifically, chemical and spectral analyses have confirmed the presence of baicalein, naringin, and neohesperidin within the plant. Together, these various compounds highlight the significant pharmacological potential of Tadehagi triquetrum in addressing metabolic conditions.
Conditions
Tadehagi triquetrum demonstrates significant therapeutic potential through its ability to treat several physiological and molecular conditions. The aqueous extract of this plant effectively suppresses cellular senescence by downregulating the expression of the senescence-related proteins P16, P21, and P53. Furthermore, the plant exhibits anthelminthic bioactivity, specifically through the presence of prenylated isoflavones like triquetrumone C. It also serves as an effective antidiabetic agent, with certain phenylpropanoid glucosides enhancing glucose uptake in myotubes. These diverse biological activities highlight the plant's multifaceted medicinal utility.
Preparations
Tadehagi triquetrum is prepared as an aqueous extract to investigate its ability to ameliorate diabetic kidney disease by mitigating epithelial senescence through the PTEN/AKT/mTOR signaling pathway. This aqueous extract has been shown to improve renal function and suppress cellular senescence in both in vivo and in vitro models. Additionally, Tadehagi triquetrum is prepared as an ethanol extract for the investigation of its anthelmintic bioactive compounds. The study of this ethanol extract led to the isolation of four new prenylated isoflavonoids, including triquetrumones A, B, and C. These isolated compounds from the ethanol preparation demonstrated mild anthelmintic bioactivity and specific binding abilities to the estrogen receptor.